Weigao Group repurchases 62,000 H shares at HKD 3.50–3.51; treasury stock rises to 56.28 million

Bulletin Express05-21

Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed that on 21 May 2026 it bought back 62,000 H shares on the Hong Kong Stock Exchange, paying between HKD 3.50 and HKD 3.51 per share. The aggregate consideration amounted to HKD 217,400 (approximately 0.22 million).

Following the transaction, the company’s outstanding issued share capital (excluding treasury shares) declined by 62,000 shares, or 0.0014%, to 4.47 billion. Treasury shares increased correspondingly from 56.21 million to 56.28 million, leaving total issued shares unchanged at 4.52 billion.

The buy-back forms part of the mandate approved by shareholders on 27 May 2025, which authorises the repurchase of up to 451.56 million shares. To date, 49.63 million shares—equivalent to 10.99% of the issued share base at the time of the mandate—have been repurchased under this authority.

In accordance with Main Board Rule 10.06, Weigao Group is subject to a moratorium on issuing new shares or selling treasury shares until 21 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187328921?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-21 17:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187328921","market":"hk","top_or_hot":-1,"title":"Weigao Group repurchases 62,000 H shares at HKD 3.50–3.51; treasury stock rises to 56.28 million","media":"Bulletin Express","content":"<p>Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed that on 21 May 2026 it bought back 62,000 H shares on the Hong Kong Stock Exchange, paying between HKD 3.50 and HKD 3.51 per share. The aggregate consideration amounted to HKD 217,400 (approximately 0.22 million).</p>\n<p>Following the transaction, the company’s outstanding issued share capital (excluding treasury shares) declined by 62,000 shares, or 0.0014%, to 4.47 billion. Treasury shares increased correspondingly from 56.21 million to 56.28 million, leaving total issued shares unchanged at 4.52 billion.</p>\n<p>The buy-back forms part of the mandate approved by shareholders on 27 May 2025, which authorises the repurchase of up to 451.56 million shares. To date, 49.63 million shares—equivalent to 10.99% of the issued share base at the time of the mandate—have been repurchased under this authority.</p>\n<p>In accordance with Main Board Rule 10.06, Weigao Group is subject to a moratorium on issuing new shares or selling treasury shares until 21 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Weigao Group repurchases 62,000 H shares at HKD 3.50–3.51; treasury stock rises to 56.28 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWeigao Group repurchases 62,000 H shares at HKD 3.50–3.51; treasury stock rises to 56.28 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-05-21 17:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed that on 21 May 2026 it bought back 62,000 H shares on the Hong Kong Stock Exchange, paying between HKD 3.50 and HKD 3.51 per share. The aggregate consideration amounted to HKD 217,400 (approximately 0.22 million).</p>\n<p>Following the transaction, the company’s outstanding issued share capital (excluding treasury shares) declined by 62,000 shares, or 0.0014%, to 4.47 billion. Treasury shares increased correspondingly from 56.21 million to 56.28 million, leaving total issued shares unchanged at 4.52 billion.</p>\n<p>The buy-back forms part of the mandate approved by shareholders on 27 May 2025, which authorises the repurchase of up to 451.56 million shares. To date, 49.63 million shares—equivalent to 10.99% of the issued share base at the time of the mandate—have been repurchased under this authority.</p>\n<p>In accordance with Main Board Rule 10.06, Weigao Group is subject to a moratorium on issuing new shares or selling treasury shares until 21 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01066","symbol_name":"威高股份","start_time":0,"source_url":"","article_id":"1187328921","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187328921","pubTimestamp":1779355473,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed that on 21 May 2026 it bought back 62,000 H shares on the Hong Kong Stock Exchange, paying between HKD 3.50 and HKD 3.51...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01066":"威高股份"},"translate_title":"威高集团3.50-3.51港元回购6.2万股H股；库存股升至5628万股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01066":1},"content_text":"Shandong Weigao Group Medical Polymer Company Limited (Weigao Group) disclosed that on 21 May 2026 it bought back 62,000 H shares on the Hong Kong Stock Exchange, paying between HKD 3.50 and HKD 3.51 per share. The aggregate consideration amounted to HKD 217,400 (approximately 0.22 million).\nFollowing the transaction, the company’s outstanding issued share capital (excluding treasury shares) declined by 62,000 shares, or 0.0014%, to 4.47 billion. Treasury shares increased correspondingly from 56.21 million to 56.28 million, leaving total issued shares unchanged at 4.52 billion.\nThe buy-back forms part of the mandate approved by shareholders on 27 May 2025, which authorises the repurchase of up to 451.56 million shares. To date, 49.63 million shares—equivalent to 10.99% of the issued share base at the time of the mandate—have been repurchased under this authority.\nIn accordance with Main Board Rule 10.06, Weigao Group is subject to a moratorium on issuing new shares or selling treasury shares until 21 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187328921","isCrawlerRequest":true}